Current Real-World Treatment Patterns And Outcomes In Patients With Relapsed/Refractory Multiple Myeloma

JOURNAL OF CLINICAL ONCOLOGY(2018)

引用 1|浏览12
暂无评分
摘要
Introduction: Limited real-world data exist on treatments for relapsed/refractory multiple myeloma (RRMM) since the approval of several new agents. This study assessed treatment patterns and outcomes of patients with RRMM receiving ≥2 lines of therapy in US community oncology practices.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要